IV nitroglycerine alternatives: Difference between revisions
ClaireLewis (talk | contribs) |
|||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 2: | Line 2: | ||
*Suggestions for substitution during the IV shortage | *Suggestions for substitution during the IV shortage | ||
===Nitroglycerine Bioavailability=== | ===[[Nitroglycerine]] Bioavailability=== | ||
*Oral <ref name="availability">http://sepia.unil.ch/pharmacology/index.php?id=51</ref>: <1% | *Oral <ref name="availability">http://sepia.unil.ch/pharmacology/index.php?id=51</ref>: <1% | ||
*Sublingual <ref name="availability"/>: 38% (15-40%) | *Sublingual <ref name="availability"/>: 38% (15-40%) | ||
| Line 25: | Line 25: | ||
<references> | <references> | ||
[[Category: | [[Category:Pharmacology]] | ||
[[Category:Cardiology]] | |||
Latest revision as of 20:51, 22 September 2019
Background
- Suggestions for substitution during the IV shortage
Nitroglycerine Bioavailability
Half-life[2]: 0.05 h
Suggested Substitutions[3]
- Sublingual nitroglycerin, 1-2 tabs or sprays every 5 minutes as needed
- Once controlled
- Nitroprusside OR Isordil PO (nitro paste or longer acting NTG)
- If not well controlled
- IV enalapril 0.625-1.25mg IV bolus
- IV hydralazine 5-10mg IV bolus
- IV nitroprusside
- Once controlled
See Also
References
<references>